Specola N

Language: Spanish
References: 10
Page: 340-342
PDF size: 109.76 Kb.

ABSTRACT

Untreated phenylketonuria (PKU) causes cognitive, neuropsychological and motor skills impairment as well as microcephaly and demyelization. Persistent hyperphenylalaninemia produces toxicity on neurons and glial cells, alters cortical development, growth and dendritic density High levels of phenylalanine and low levels of neutral aminoacids in the brain disrupt neurotransmitter synthesis, increase oxidative damage, reduce the number of dopaminergic neurons and decrease the length of dendrites. White matter lesions are not present in all patients and there is no relation between these lesions and clinical severity. It has been shown that selenium and carnitine supplementation can decrease lipid and protein peroxidation. There are several mechanisms involved in neurodegeneration of patients with phenylketonuria; early treatment and strict nutritional control significantly improve the prognosis of these patients.

REFERENCES

1. Embury JE, Charron CE, Martynyuk A, Zori AG, Liu B, Ali SF, Rowland NE, Laipis PJ. PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice. Brain Res 2007;1127:136-50.

2. Kaufman S. A model of human phenylalanine metabolism in normal subjects and in phenylketonuric patients. Proc Natl Acad Sci U S A 1999;96(6):3160-4.

3. Puglisi-Allegra S, Cabib S, Pascucci T, Ventura R, Cali F, Romano V. Dramatic brain aminergic deficit in a genetic mouse model of phenylketonuria. Neuroreport 2000;11:1361-4.

4. Sirtori LR Sirtori LR, Dutra-Filho CS, Fitarelli D, Sitta A, Haeser A, Barschak AG, Wajner M, Coelho DM, Llesuy S, Belló-Klein A, Giugliani R, Deon M, Vargas CR. Oxidative stress in patients with phenylketonuria. Biochem Biophys Acta 2005;1740:68-73.

5. Huttenlocher PR. The neuropathology of phenylketonuria: human and animal studies. Eur J Pediatr 2000;159(Suppl 2):S102-6.

6. Sirrs SM, Laule C, Mädler B, Brief EE, Tahir SA, Bishop C, MacKay AL. Normal-appearing white matter in patients with phenylketonuria: water content, myelin water fraction, and metabolite concentrations. Radiology 2007;242:236-43.

7. van Spronsen FJ, Hoeksma M, Reijngoud DJ. Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 2009;32:46-51.

8. Pérez-Dueñas B, Pujol J, Soriano-Mas C, Ortiz H, Artuch R, Vilaseca MA, Campistol J. Global and regional volume changes in the brains of patients with phenylketonuria. Neurology 2006;66:1074–8.

9. Li D, Gu X, Lu L, Liang L. Effects of phenylalanine on the survival and neurite outgrowth of rat cortical neurons in primary cultures: possible involvement of brain-derived neurotrophic factor. Mol Cell Biochem 2010;339:1–7.

10. Anderson PJ, Leuzzi V. White matter pathology in phenylketonuria. Mol Genet Metab 2010;99(suppl):S3-S9.